Log In
BCIQ
Print this Print this
 

VLT-001

  Manage Alerts
Collapse Summary General Information
Company Valentia Biopharma S.L.
DescriptionSmall peptide with anti-DM1 activity
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationMyotonic dystrophy type 1 (DM1)
Indication DetailsTreat myotonic dystrophy type 1 (DM1)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today